Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker
Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker has been studied in 1 paper since 2026: none in people yet, 1 review; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Sep 11, 2026: “The translational gap in quadruple heart failure therapy in East and Southeast Asia: Barriers and a…”.
1 paper studies itUpdated
See all 1 papers on angiotensin-converting enzyme inhibitor or angiotensin receptor blocker
Latest
1 paper in 12 monthsJournal of Clinical and Translational Research
The translational gap in quadruple heart failure therapy in East and Southeast Asia: Barriers and a proposed phenotype-adapted implementation model
ReviewInterventions